OncologyThe Integration Of The Nellcor™ OxiMax™ SpO2 System Into Philips Patient Monitors Announced By Covidien
Covidien (NYSE: COV), a leading global supplier of healthcare products, has announced the integration of its Nellcor™ OxiMax™ oximetry system into Philips IntelliVue and M-Series patient monitors. Philips is a leading global provider of patient monitoring solutions, and the collaboration between the companies is expected to significantly increase, in all major geographies, hospitals" and healthcare providers" access to the industry-leading capabilities offered by both companies.
Customers will have the added flexibility of choosing the Nellcor OxiMax technology in Philips IntelliVue and M-Series patient monitors for critical care areas such as the Intensive Care, Emergency, Anesthesia and Neonatal Care departments. This enables the IntelliVue and M-Series patient monitors to be compatible with Covidien"s Nellcor OxiMax specialty sensors, including the Max-Fast™ forehead sensor for patients with poor perfusion and the SoftCare™ nonadhesive sensor line for patients with sensitive skin, including newborns. In the intensive care unit and other high-acuity areas of the hospital, Max-Fast and SoftCare sensors support effective, comfortable care for the most critical patients.
"Hospitals and clinicians are under constant pressure to improve outcomes and decrease costs. In turn, they are demanding expanded access to the technologies and medical devices they trust," said Chris Lowery, General Manager and Vice President, Patient Monitoring, Covidien. "Covidien"s partnership with Philips gives hospitals access to advanced technology from two leading medical monitoring companies. The successful completion of this collaboration with Philips, a recognized industry leader in patient monitoring, is consistent with Covidien"s mission to provide products that help clinicians deliver safe and efficacious patient care, while simultaneously maximizing hospital efficiency."
"Many clinicians have expressed great interest in Nellcor OxiMax technology in our IntelliVue patient monitors," said David Russell, Vice President and Chief Marketing Officer, Informatics and Patient Monitoring, Philips Healthcare. "This collaboration enhances our ability to provide customers in the USA, Europe and many other markets with a choice of their preferred trusted pulse oximetry technology. This partnership also underscores Philips" commitment to providing clear, accurate information to support clinical decision-making across all areas of the hospital."
Katherine Tripple
Feinstein Kean Healthcare